Revolution Medicines RVMD
NASDAQ RVMD
$177.96 -11.30 (-5.97%)
At close: Oct 16, 2026 · 4:00 PM EDT

Revolution Medicines (RVMD) Preferred Stock Liabilities (2019)

Updated

Revolution Medicines (RVMD) recorded Preferred Stock Liabilities of $305.11 million in Q4 2019, unchanged from the prior quarter.

Analysis

Revolution Medicines (RVMD) Preferred Stock Liabilities (2019) Analysis & Trends

Starting with Q1 2019, Revolution Medicines' Preferred Stock Liabilities history includes 4 quarters.

  • Across earlier years, Preferred Stock Liabilities came in at $205.08 million in FY2018.
  • Quarterly Preferred Stock Liabilities has ranged from $205.08 million in Q1 2019 to $305.11 million in Q3 2019 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $305.11 million (Q3 2019), $295.02 million (Q2 2019) and $205.08 million (Q1 2019).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn -
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn -
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn -
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn -
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn -
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn -
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn -
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn -
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn -
10 Revolution Medicines 37.70 Bn 27.90 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 305.11 Mn
Sep 30, 2019 305.11 Mn
Jun 30, 2019 295.02 Mn
Mar 31, 2019 205.08 Mn
API Access

Revolution Medicines Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=RVMD&period=max&api_key=YOUR_API_KEY